GlassScriptPhysician profile
Erik A Bowman
NPI 1942434659
$3,061.61
in general payments reported to CMS, 2019-2025
12 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $177 · 2021: $211 · 2022: $227 · 2023: $329 · 2024: $1,322 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Travel and Lodging: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.58 |
| Travel and Lodging | $735.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,022.60 | 2019-2025 | Exalt Model D, Acquire, Spyglass |
| Depuy Synthes Sales INC. | $305.27 | 2022-2024 | Na, Va-Lcp, Fibergraft Aeridyan Matrix |
| Aimmune Therapeutics, INC. | $180.57 | 2024 | |
| Olympus America INC. | $156.06 | 2019-2020 | |
| Abbvie INC. | $120.72 | 2021-2025 | Rinvoq |
| Zimmer Biomet Holdings, INC. | $104.18 | 2019 | |
| Pfizer INC. | $56.67 | 2019 | |
| Amgen INC. | $36.30 | 2025 | Uplizna |
| Gilead Sciences, INC. | $31.48 | 2020-2022 | |
| Celgene Corporation | $29.50 | 2021-2022 | |
| Medtronic, INC. | $13.11 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $5.15 | 2024 | Abc Balloons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.